Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Practice patterns and opinions in the treatment of acanthamoeba keratitis.

Oldenburg CE, Acharya NR, Tu EY, Zegans ME, Mannis MJ, Gaynor BD, Whitcher JP, Lietman TM, Keenan JD.

Cornea. 2011 Dec;30(12):1363-8. doi: 10.1097/ICO.0b013e31820f7763.

2.

[Diagnostics and treatment of infectious keratitis].

Szentmáry N, Módis L, Imre L, Füst Á, Daas L, Laurik L, Seitz B, Nagy ZZ.

Orv Hetil. 2017 Aug;158(31):1203-1212. doi: 10.1556/650.2017.30821. Review. Hungarian.

PMID:
28758436
3.

Treatment of Acanthamoeba keratitis.

Lindquist TD.

Cornea. 1998 Jan;17(1):11-6. Review.

PMID:
9436874
4.

Diagnosis and successful medical treatment of Acanthamoeba keratitis.

D'Aversa G, Stern GA, Driebe WT Jr.

Arch Ophthalmol. 1995 Sep;113(9):1120-3.

PMID:
7661744
5.

Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.

Polat ZA, Walochnik J, Obwaller A, Vural A, Dursun A, Arici MK.

Clin Exp Ophthalmol. 2014 Mar;42(2):151-8. doi: 10.1111/ceo.12120. Epub 2013 May 21.

PMID:
23601234
6.

[Anti-infective drug therapy in ophthalmology--part 4: acanthamoeba keratitis].

Reinhard T, Behrens-Baumann W.

Klin Monbl Augenheilkd. 2006 Jun;223(6):485-92. Review. German.

PMID:
16804818
7.

Diagnosis and management of Acanthamoeba keratitis.

Hammersmith KM.

Curr Opin Ophthalmol. 2006 Aug;17(4):327-31. Review.

PMID:
16900022
8.

Perioperative treatment and prognostic factors for penetrating keratoplasty in Acanthamoeba keratitis unresponsive to medical treatment.

Shi W, Liu M, Gao H, Li S, Xie L.

Graefes Arch Clin Exp Ophthalmol. 2009 Oct;247(10):1383-8. doi: 10.1007/s00417-009-1103-9. Epub 2009 May 9.

PMID:
19424711
9.

Treatment of Acanthamoeba keratitis.

Seal D.

Expert Rev Anti Infect Ther. 2003 Aug;1(2):205-8. Review.

PMID:
15482114
10.

The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis.

Robaei D, Carnt N, Minassian DC, Dart JK.

Ophthalmology. 2014 Jul;121(7):1383-8. doi: 10.1016/j.ophtha.2014.01.031. Epub 2014 Mar 14.

PMID:
24630688
11.

Update on Acanthamoeba Keratitis: Diagnosis, Treatment, and Outcomes.

Maycock NJ, Jayaswal R.

Cornea. 2016 May;35(5):713-20. doi: 10.1097/ICO.0000000000000804. Review.

PMID:
26989955
12.

[The German Acanthamoeba keratitis register: Initial results of a multicenter study].

Daas L, Szentmáry N, Eppig T, Langenbucher A, Hasenfus A, Roth M, Saeger M, Nölle B, Lippmann B, Böhringer D, Reinhard T, Kelbsch C, Messmer E, Pleyer U, Roters S, Zhivov A, Engelmann K, Schrecker J, Zumhagen L, Thieme H, Darawsha R, Meyer-Ter-Vehn T, Dick B, Görsch I, Hermel M, Kohlhaas M, Seitz B.

Ophthalmologe. 2015 Sep;112(9):752-63. doi: 10.1007/s00347-014-3225-7. German. Erratum in: Ophthalmologe. 2015 Nov;112(11):942.

PMID:
25833754
13.

New approach to diagnosis and treatment of Acanthamoeba keratitis--systematic review of literature.

Kokot J, Dobrowolski D, Lyssek-Boroń A, Milka M, Smedowski A, Wójcik Ł, Wowra B, Wyligała E.

Klin Oczna. 2012;114(4):311-6. Review.

PMID:
23461162
14.

Acanthamoeba keratitis after photorefractive keratectomy.

Kaldawy RM, Sutphin JE, Wagoner MD.

J Cataract Refract Surg. 2002 Feb;28(2):364-8.

PMID:
11821223
15.

The role of topical corticosteroids in the management of Acanthamoeba keratitis.

Park DH, Palay DA, Daya SM, Stulting RD, Krachmer JH, Holland EJ.

Cornea. 1997 May;16(3):277-83.

PMID:
9143798
16.

[Acanthamoeba keratitis].

Bouheraoua N, Labbé A, Chaumeil C, Liang Q, Laroche L, Borderie V.

J Fr Ophtalmol. 2014 Oct;37(8):640-52. doi: 10.1016/j.jfo.2014.05.004. Epub 2014 Aug 29. Review. French.

17.

The clinical experience of Acanthamoeba keratitis at a tertiary care eye hospital.

Tanhehco T, Colby K.

Cornea. 2010 Sep;29(9):1005-10. doi: 10.1097/ICO.0b013e3181cf9949.

PMID:
20539211
18.

[Delayed course of Acanthamoeba keratitis].

Schnaidt AG, Gatzioufas Z, Schirra F, Hasenfus AK, Seitz B.

Ophthalmologe. 2013 Feb;110(2):164-8. doi: 10.1007/s00347-012-2707-8. German.

PMID:
23224124
19.

Clinical outcomes and prognostic factors associated with acanthamoeba keratitis.

Chew HF, Yildiz EH, Hammersmith KM, Eagle RC Jr, Rapuano CJ, Laibson PR, Ayres BD, Jin YP, Cohen EJ.

Cornea. 2011 Apr;30(4):435-41. doi: 10.1097/ICO.0b013e3181ec905f.

PMID:
21045665
20.

Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis.

Lim N, Goh D, Bunce C, Xing W, Fraenkel G, Poole TR, Ficker L.

Am J Ophthalmol. 2008 Jan;145(1):130-5. Epub 2007 Nov 8.

PMID:
17996208

Supplemental Content

Support Center